-
Role
-
Co-CEO, Director
-
Signature
-
By: Veronique Bourdeau, Authorized Signatory For: Gregory K. Peters
-
Stock symbol
-
NFLX
-
Transactions as of
-
Jan 24, 2024
-
Transactions value $
-
-$6,060,980
-
Form type
-
4
-
Date filed
-
1/26/2024, 05:52 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
NFLX |
Common Stock |
+Options Exercise |
$682,342 |
+7,007 |
+53.53% |
$97.38 |
20,097 |
Jan 24, 2024 |
Direct |
|
transaction |
NFLX |
Common Stock |
+Options Exercise |
$682,284 |
+6,648 |
+33.08% |
$102.63 |
26,745 |
Jan 24, 2024 |
Direct |
|
transaction |
NFLX |
Common Stock |
-Sell |
-$3,769,205 |
-7,007 |
-26.2% |
$537.92 |
19,738 |
Jan 24, 2024 |
Direct |
F1 |
transaction |
NFLX |
Common Stock |
-Sell |
-$3,656,400 |
-6,648 |
-33.68% |
$550.00 |
13,090 |
Jan 24, 2024 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
NFLX |
Restricted Stock Units |
+Grant/Award |
$0 |
+31,112 |
|
$0.00 |
31,112 |
Jan 25, 2024 |
Common Stock |
31,112 |
|
Direct |
F2, F3 |
transaction |
NFLX |
Non-Qualified Stock Option (right to buy) |
-Options Exercise |
$0 |
-7,007 |
-100% |
$0.00 |
0 |
Jan 24, 2024 |
Common Stock |
7,007 |
$97.38 |
Direct |
F1 |
transaction |
NFLX |
Non-Qualified Stock Option (right to buy) |
-Options Exercise |
$0 |
-6,648 |
-100% |
$0.00 |
0 |
Jan 24, 2024 |
Common Stock |
6,648 |
$102.63 |
Direct |
F1 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: